How big is the stem cell therapy market?

The global stem cell therapy market size was estimated at USD 456.0 million in 2024 and is expected to reach USD 542.2 million in 2025.

What is the stem cell therapy market growth?

The global stem cell therapy market is expected to witness a compound annual growth rate of 25.23% from 2025 to 2030 to reach USD 1,670.1 million by 2030.

Which segment accounted for the largest stem cell therapy market share?

The allogeneic stem cell therapies segment dominated the market with a share of 69.22% in 2024. The large share is propelled by several factors contributing to its expansion, including the increasing research landscape and clinical trials within the allogenic stem cell field.

Who are the key players in stem cell therapy market?

Some of the key players operating in the stem cell therapy market include Bluebird bio, Inc., NIPRO, Kyowa Kirin, Pharmicell Co., Ltd., CorestemChemon Inc., ANTEROGEN.CO., LTD., Holostem S.r.l., Vertex Pharmaceuticals, Inc., Cleveland Cord Blood Center, and Highbridge Capital Management

What are the factors driving the stem cell therapy market?

One of the primary driving factors of the market is the increasing incidence of chronic diseases and degenerative disorders, such as cancer and cardiovascular diseases, which has led to a search for new treatment options. Stem cell therapy offers the potential to regenerate damaged tissues and organs, providing hope for patients suffering from these debilitating conditions.